Global News

[ad_1] Infection with the SARS-CoV-2 virus may significantly accelerate dementia in patients already suffering from the neurodegenerative condition, according to a study conducted in West Bengal. The research, published in the Journal of Alzheimer's Disease Reports, found that participants with all subtypes of dementia experienced rapidly progressive dementia following infection with SARS-CoV-2. Insights into the impact of Covid-19 on human cognition have so far remained unclear, with neurologists referring to it as "brain fog." The researchers investigated the effects of Covid-19 on cognitive impairment in 14 patients with preexisting dementia who had suffered further cognitive deterioration following the infection with SARS-CoV-2. The patients included four with Alzheimer's disease, five with vascular dementia, three with Parkinson's disease, and two with the behavioral variant of frontotemporal dementia. They were recruited out of a total of 550 patie

[ad_1] FDA gives full approval to a drug designed to slow Alzheimer's disease - CBS News Watch CBS News The Food and Drug Administration on Thursday gave its approval to Leqembi, a drug designed to slow the progression of Alzheimer's disease. Leqembi is not considered a cure for Alzheimer’s, but will be covered by Medicare. Dr. Jon LaPook has more. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On [ad_2] Source link https://worldnews2023.com/health/fda-gives-full-approval-to-a-drug-designed-to-slow-alzheimers-disease/?feed_id=309338&_unique_id=668b8fdb27ad1

[ad_1] Sight loss in people over 71 years old may be linked to dementia, suggests a new study. The researchers at the University of Michigan in the US analysed data from nearly 3,000 US citizens over 71 years old. They tested the participants' eyesight and recorded their scores for short-distance vision, long-distance vision and how well they were able to distinguish objects against different backgrounds. The findings, published in the Journal of the American Medical Association (JAMA) Ophthalmology, showed that participants with sight loss were more likely to have dementia compared to people with no problems with their vision. Up to 40 per cent of dementia cases could be influenced by 12 risk factors which we may prevent or influence, such as smoking, high blood pressure and hearing loss. Sight loss is not currently one of these 12 important risk factors, but the new evidence suggests that there is a link between sight loss and dementia, the researchers said. cre Trendi

[ad_1] FDA gives full approval to a drug designed to slow Alzheimer's disease - CBS News Watch CBS News The Food and Drug Administration on Thursday gave its approval to Leqembi, a drug designed to slow the progression of Alzheimer's disease. Leqembi is not considered a cure for Alzheimer’s, but will be covered by Medicare. Dr. Jon LaPook has more. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On [ad_2] Source link https://worldnews2023.com/health/fda-gives-full-approval-to-a-drug-designed-to-slow-alzheimers-disease/?feed_id=22351&_unique_id=64a758f4376ea